Edition:
India

Tonix Pharmaceuticals Holding Corp (TNXP.OQ)

TNXP.OQ on NASDAQ Stock Exchange Global Market

3.62USD
17 Nov 2017
Change (% chg)

$0.02 (+0.56%)
Prev Close
$3.60
Open
$3.61
Day's High
$3.71
Day's Low
$3.58
Volume
11,358
Avg. Vol
17,759
52-wk High
$9.38
52-wk Low
$2.85

Latest Key Developments (Source: Significant Developments)

Tonix Pharmaceuticals Q3 loss per share $0.77
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Tonix Pharmaceuticals Holding Corp :Tonix Pharmaceuticals reports third quarter 2017 financial results and provides programs update.Q3 loss per share $0.77.Tonix Pharmaceuticals Holding Corp - ‍at September 30, 2017, Tonix had cash and cash equivalents of $29.3 million​.  Full Article

Tonix Pharma reports outcomes from CMC guidance meeting with FDA on Tonmya
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Tonix Pharmaceuticals Holding Corp :Tonix Pharmaceuticals reports outcomes from U.S. FDA breakthrough therapy CMC guidance meeting of Tonmya® (cyclobenzaprine hci sublingual tablets) for PTSD.Tonix Pharmaceuticals Holding Corp - ‍proposed CMC data package to support Tonmya's NDA and commercial manufacturing plans was accepted by FDA​.Tonix Pharmaceuticals Holding - ‍FDA official minutes reflect co's readiness to manufacture Tonmya commercial product at production scale​.Tonix Pharmaceuticals Holding - ‍Tonmya has been conditionally accepted by FDA as proposed trade name for TNX-102 SL (cyclobenzaprine hcl sublingual tablets) for PTSD​.  Full Article

Tonix Pharmaceuticals Q2 loss per share $0.50
Monday, 8 Aug 2016 

Tonix Pharmaceuticals Holding Corp : Tonix Pharmaceuticals reports second quarter 2016 financial results and provides programs update . Q2 earnings per share view $-0.55 -- Thomson Reuters I/B/E/S .Q2 loss per share $0.50.  Full Article

Tonix Pharmaceuticals prices underwritten offering of stock
Thursday, 16 Jun 2016 

Tonix Pharmaceuticals Holding Corp : Underwritten public offering of 5 million shares priced at $2.00 per share .Tonix pharmaceuticals prices underwritten public offering of common stock.  Full Article

Tonix Pharmaceuticals announces proposed public offering
Thursday, 16 Jun 2016 

Tonix Pharmaceuticals Holding Corp : Tonix Pharmaceuticals announces proposed public offering of common stock .Expects to use net proceeds to support continued development of TNX-102 SL.  Full Article

Tonix Pharmaceuticals Q1 loss per share $0.74
Monday, 9 May 2016 

Tonix Pharmaceuticals Holding Corp : Tonix Pharmaceuticals reports first quarter 2016 financial results and provides programs update . Q1 loss per share $0.74 .Q1 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S.  Full Article

Tonix Pharmaceuticals Holding announces management change
Saturday, 9 Jan 2016 

Tonix Pharmaceuticals Holding Corp:Announced that Jessica Edgar Morris, Chief Administrative Officer, has been appointed Acting Chief Financial Officer, effective immediately.Morris replaces Leland J. Gershell.  Full Article

BRIEF-Tonix Pharmaceuticals Q3 loss per share $0.77

* Tonix Pharmaceuticals reports third quarter 2017 financial results and provides programs update